Journal
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 22, Issue 8, Pages 523-529Publisher
OXFORD UNIV PRESS
DOI: 10.1093/protein/gzp038
Keywords
binding and conversion domains; misfolding; monoclonal antibody; prion
Funding
- Government of Canada
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council
- A. P. Sloan Foundation
- Michael Smith Foundation for Health Research
Ask authors/readers for more resources
Prion diseases are associated with the conversion of cellular prion protein (PrPC) to an abnormal protease-resistant conformational isoform (PrPSc) by template-directed conversion. The interaction between PrPC and PrPSc is mediated by specific sites which have been mapped to six putative 'binding and conversion domains' (PrP-BCD) through peptide and antibody competition studies. Monoclonal antibodies (mAbs) directed against the bityrosine motif Tyr-Tyr-Arg (YYR) specifically recognize PrPSc and other misfolded PrP species. Here, we report that select bead-bound PrP-BCD mAbs induce exposure of bityrosine epitopes on mouse brain PrP. By competition immunoprecipitation, we show that PrP-BCD mAb-induced bityrosine exposure occurs at alpha-helices 1 and 3. However, PrP-BCD mAb-induced PrPC misfolding is not accompanied by beta-sheet dissociation, a key event in PrPC conversion to PrPSc, and is not associated with acquisition of protease resistance, or the capacity to recruit additional molecules of PrP. Our data suggest that mAb mimics of the physical interaction of PrPC with PrPSc can induce unfolding of specific PrP domains, but that subsequent processes (including the energetically unfavorable beta-sheet dissociation) effect isoform conversion in prion disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available